| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Chief Scientific Officer
1 company
Erlander Mark is a Chief Executive Officer at Cardiff Oncology, Inc.. Recent SEC Form 4 filings include 4 buys and 0 sells.
Estimated insider holdings value: $40K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 25, 2022 | CRDF Cardiff Oncology, Inc. | Chief Executive Officer | Buy | 10,000 | $1.43 | $14,300.00 | +69.1% | +27.3% | -12.2% | |
| Mar 23, 2021 | CRDF Cardiff Oncology, Inc. | Chief Executive Officer | Buy | 965 | $10.34 | $9,979.74 | +7.1% | -22.3% | -75.7% | |
| May 14, 2020 | CRDF Cardiff Oncology, Inc. | Chief Executive Officer | Buy | 6,993 | $1.43 | $9,999.99 | +109.7% | - | - | |
| Dec 14, 2016 | CRDF Cardiff Oncology, Inc. | Chief Scientific Officer | Buy | 5,000 | $2.08 | $10,375.00 | New | - | - |